{"id":8553,"date":"2020-11-06T13:25:07","date_gmt":"2020-11-06T12:25:07","guid":{"rendered":"http:\/\/oncomatryx.com\/?p=8553"},"modified":"2020-11-06T13:25:07","modified_gmt":"2020-11-06T12:25:07","slug":"pegs2020-2","status":"publish","type":"post","link":"https:\/\/oncomatryx.com\/es\/pegs2020-2\/","title":{"rendered":"PEGS Europe Virtual Summit 2020"},"content":{"rendered":"<h1><a href=\"http:\/\/oncomatryx.com\/wp-content\/uploads\/2020\/11\/PEGS-2020.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone size-large wp-image-8554\" src=\"http:\/\/oncomatryx.com\/wp-content\/uploads\/2020\/11\/PEGS-2020-1024x192.png\" alt=\"PEGS 2020\" width=\"700\" height=\"131\" \/><\/a><\/h1>\n<h1><span style=\"color: #99ccff;\">12 Annual PEGS Europe Virtual Summit 2020<\/span><\/h1>\n<h2><span style=\"color: #99ccff;\">9 Nov &#8211; 12 Nov 2020<\/span><\/h2>\n<p>Myriam Fabre, PhD. (Oncomatryx R&amp;D Director) will attend the virtual conference as a speaker on next Tuesday 10 November, in the session included in the section \u00abNext generation ADCs\u00bb:<\/p>\n<p><strong>OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models<\/strong><\/p>\n<p>She will be also a moderator in the Panel Discussion that concludes the session \u201cImproving the therapeutic index in ADCs\u00bb<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>12 Annual PEGS Europe Virtual Summit 2020 9 Nov &#8211; 12 Nov 2020 Myriam Fabre, PhD. (Oncomatryx R&amp;D Director) will attend the virtual conference as a speaker on next Tuesday 10 November, in the session included in the section \u00abNext generation ADCs\u00bb: OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor &#8230; <a title=\"PEGS Europe Virtual Summit 2020\" class=\"read-more\" href=\"https:\/\/oncomatryx.com\/es\/pegs2020-2\/\" aria-label=\"Leer m\u00e1s sobre PEGS Europe Virtual Summit 2020\">Leer m\u00e1s<\/a><\/p>\n","protected":false},"author":4,"featured_media":8570,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[18],"tags":[],"class_list":["post-8553","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/posts\/8553","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/comments?post=8553"}],"version-history":[{"count":0,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/posts\/8553\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/media?parent=8553"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/categories?post=8553"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/tags?post=8553"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}